← Back to directory

Roberto Cauda

Researcher Next ID · RN-019430

Researcher · Immunology and Microbiology

Università Cattolica del Sacro Cuore

Milan, Philippines

Not currently recruitingFunding unknown
Works count
553
Citation count
21,076
H-index
67
i10-index
312

Research interests

Immunology and Microbiology
Medicine
HIV Research and Treatment
HIV/AIDS drug development and treatment
HIV/AIDS Research and Interventions
HIV-related health complications and treatments
Pneumocystis jirovecii pneumonia detection and treatment

Publications

  • Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study

    Clinical Infectious Diseases · 2021 · 10.1093/cid/ciab176

  • Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy

    Journal of Infection · 2020 · 10.1016/j.jinf.2020.03.058

  • Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study

    Nutrition Metabolism and Cardiovascular Diseases · 2020 · https://doi.org/10.1016/j.numecd.2020.07.031

  • Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused byKlebsiella pneumoniaeCarbapenemase–producingK. pneumoniae

    Clinical Infectious Diseases · 2018 · 10.1093/cid/ciy492

  • Infections caused by KPC-producing Klebsiella pneumoniae : differences in therapy and mortality in a multicentre study

    Journal of Antimicrobial Chemotherapy · 2015 · 10.1093/jac/dkv086

  • Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case–control–control study

    Clinical Microbiology and Infection · 2015 · 10.1016/j.cmi.2015.08.001

  • Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study

    Clinical Microbiology and Infection · 2014 · 10.1111/1469-0691.12747

  • Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy

    Clinical Infectious Diseases · 2012 · https://doi.org/10.1093/cid/cis588

  • Risk Factors and Outcomes of Candidemia Caused by Biofilm-Forming Isolates in a Tertiary Care Hospital

    PLoS ONE · 2012 · 10.1371/journal.pone.0033705

  • Identifying Patients Harboring Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae on Hospital Admission: Derivation and Validation of a Scoring System

    Antimicrobial Agents and Chemotherapy · 2011 · 10.1128/aac.00009-11

  • Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients

    Neurology · 2011 · 10.1212/wnl.0b013e31821670fb

  • Costs of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum-β-Lactamase Production and Inadequate Initial Antibiotic Therapy

    Antimicrobial Agents and Chemotherapy · 2010 · https://doi.org/10.1128/aac.00143-10

  • Incidence and clinical impact of extended-spectrum-β-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies

    Journal of Infection · 2009 · https://doi.org/10.1016/j.jinf.2009.02.002

  • Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae : Importance of Inadequate Initial Antimicrobial Treatment

    Antimicrobial Agents and Chemotherapy · 2007 · 10.1128/aac.01509-06

  • Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis

    Journal of Antimicrobial Chemotherapy · 2007 · 10.1093/jac/dkm416

  • Biofilm Production by Candida Species and Inadequate Antifungal Therapy as Predictors of Mortality for Patients with Candidemia

    Journal of Clinical Microbiology · 2007 · 10.1128/jcm.00131-07

  • Benefit of Appropriate Empirical Antibiotic Treatment: Thirty-day Mortality and Duration of Hospital Stay

    The American Journal of Medicine · 2006 · https://doi.org/10.1016/j.amjmed.2006.03.034

  • New insights into the antiviral effects of chloroquine

    The Lancet Infectious Diseases · 2006 · 10.1016/s1473-3099(06)70361-9

  • Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial

    Journal of Antimicrobial Chemotherapy · 2006 · https://doi.org/10.1093/jac/dkl372

  • Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae : Risk Factors, Molecular Epidemiology, and Clinical Outcome

    Antimicrobial Agents and Chemotherapy · 2006 · 10.1128/aac.50.2.498-504.2006

  • Effects of chloroquine on viral infections: an old drug against today's diseases

    The Lancet Infectious Diseases · 2003 · https://doi.org/10.1016/s1473-3099(03)00806-5

  • Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)

    AIDS · 2002 · https://doi.org/10.1097/00002030-200202150-00008

  • Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy

    AIDS · 2001 · https://doi.org/10.1097/00002030-200108170-00005

  • In Vitro and In Vivo Anticandidal Activity of Human Immunodeficiency Virus Protease Inhibitors

    The Journal of Infectious Diseases · 1999 · https://doi.org/10.1086/314871

  • Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation

    The Journal of Immunology · 1996 · 10.4049/jimmunol.157.3.1271

Current projects

    No projects listed.